Enduring changes in brain and behavior produced by chronic amphetamine administration: A review and evaluation of animal models of amphetamine psychosis

https://doi.org/10.1016/0165-0173(86)90002-0Get rights and content

Abstract

Some people who repeatedly use stimulant drugs, such as amphetamine (AMPH), develop an AMPH-induced psychosis that is similar to paranoid schizophrenia. There has been, therefore, considerable interest in characterizing the effects of chronic stimulant drug treatment on brain and behavior in non-human animals, and in developing an animal model of AMPH psychosis. A review of this literature shows that in non-human animals chronic AMPH treatment can produce at least two different syndromes, and both of these have been proposed as animal models of AMPH psychosis. The first syndrome is called ‘AMPH neurotoxicity’, and is produced by maintaining elevated brain concentrations of AMPH for prolonged periods of time. AMPH neurotoxicity is characterized by what has been termed ‘hallucinatory-like’ behavior, which occurs in association with brain damage resulting in the depletion of striatal DA and other brain monoamines. The second syndrome is called ‘behavioral sensitization’, and is produced by the repeated intermittent administration of lower doses of AMPH. Behavioral sensitization is characterized by a progressive and enduring enhancement in many AMPH-induced behaviors, and is not accompanied by brain damage or monoamine depletion. It is argued that the changes in the brain and behavior associated with the phenomenon of behavioral sensitization provide a better ‘model’ of AMPH psychosis than those associated with AMPH neurotoxicity.

Much of the review involves a critical analysis of hypotheses regarding the biological basis of behavioral sensitization. Research on this question has focused on mesotelencephalic DA systems, and suggestions that behavioral sensitization is accompanied by:

  • 1.

    (1) an increase in postsynaptic DA receptors

  • 2.

    (2) an increase in DA synthesis

  • 3.

    (3) an increase in DA utilization and/or release

  • 4.

    (4) a decrease in DA autoreceptors, are evaluated. It is concluded that there is not convincing evidence for an increase in postsynaptic DA receptors or in DA synthesis in animals sensitized to AMPH. In contrast, there is strong evidence to support the notion that behavioral sensitization is due to enhanced mesotelencephalic DA release, especially upon re-exposure to the drug. The evidence that this enhancement in DA release is due to autoreceptor subsensitivity was found to be equivocal, and therefore other hypotheses should be entertained.

Lastly, evidence is discussed in support of the idea that behavioral sensitization is not unique to the psychopharmacology of stimulant drugs, but may be produced by many environmental stimuli that directly or indirectly activate brain catecholamine systems. For example, there are many studies showing that AMPH and stress are to some extent interchangeable in producing both behavioral sensitization and long-term changes in brain DA systems. It is concluded that sensitized animals may be hyperresponsive to any stimulus that activates brain catecholamine systems, and that the effects of sensitization are not obvious in the absence of such stimuli. This may be related to the fact that psychosis only tends to recur in former AMPH addicts following re-exposure to AMPH or stress, and that stress is considered a precipitating factor in psychiatric disorders thought to involve brain catecholamine dysfunction.

References (321)

  • J.B. Becker et al.

    Sex differences in the amphetamine-stimulated release of catecholamines from rat striatal tissue in vitro

    Brain Res.

    (1981)
  • J.B. Becker et al.

    Sex diferences and estrous cycle variations in amphetamine-elicited rotational behavior

    Eur. J. Pharmacol.

    (1982)
  • M.-J. Besson et al.

    Effects of some psychotropic drugs on tyrosine hydroxylase activity in different structures of the rat brain

    Eur. J. Pharmacol.

    (1973)
  • C.A. Brass et al.

    Sex differences in drug-induced rotation in two strains of rats

    Brain Res.

    (1981)
  • R.G. Browne et al.

    Metabolic and experiential factors in the behavioral response to repeated amphetamine

    Pharmacol. Biochem. Behav.

    (1977)
  • S. Cabib et al.

    A genetic analysis of stereotypy in the mouse: dopaminergic plasticity following chronic stress

    Behav. Neural. Biol.

    (1985)
  • J.W. Commissiong

    Monoamine metabolites: their relationship and lack of relationship to monoaminergic neuronal activity

    Biochem. Pharmacol.

    (1985)
  • M. Daiguji et al.

    Effect of chronic phencyclidine or d-amphetamine treatment on [3H]spiroperidol binding in rat caudate-putamen and nucleus accumbens

    Eur. J. Pharmacol.

    (1982)
  • G.G. Dougherty et al.

    Influence of gamma-butyrolactone on behavior due to dopaminergic drugs

    Physiol. Behav.

    (1983)
  • S.D. Echols

    Reverse tolerance to amphetamine of mice bearing unilateral striatal lesions: effect upon the circling response to apomorphine

    Life Sci.

    (1979)
  • S.D. Echols

    Circling of mice bearing unilateral striatal lesions: development of increased response to d-amphetamine

    Life Sci.

    (1977)
  • A.J. Eichler et al.

    Sensitization to amphetamine and stress may involve nucleus accumbens and medial frontal cortex

    Brain Res.

    (1979)
  • M.S. Eison et al.

    Two routes of continuous amphetamine administration induce different behavioral and neurochemical effects in the rat

    Neurosci. Lett.

    (1983)
  • E.H. Ellinwood et al.

    Effect of continuous systemic infusion of d-amphetamine on the sensitivity of nigral dopamine cells to apomorphine inhibition of firing rates

    Brain Res.

    (1983)
  • G.D. Ellison et al.

    Opposed stages of continuous amphetamine administration: parallel alterations in motor stereotypies and in vivo spiroperidol accumulation

    Eur. J. Pharmacol.

    (1981)
  • G.D. Ellison et al.

    Animal model of psychosis: hallucinatory behaviors in monkeys during the late stage of continuous amphetamine intoxication

    J. Psychiat. Res.

    (1981)
  • G.D. Ellison et al.

    The late stage following continuous amphetamine administration to rats is correlated with altered dopamine but not serotonin metabolism

    Life Sci.

    (1982)
  • J.J. Feigenbaum et al.

    The role of scheduling in amphetamine hypersensitivity and tolerance

  • H.C. Fibiger et al.

    Effect of acute and chronic methamphetamine treatment on tyrosine hydroxylase activity in brain and adrenal medulla

    Eur. J. Pharmacol.

    (1971)
  • W. Abruzzi

    Drug-induced psychosis

    Int. J. Addict.

    (1977)
  • M.D. Aceto et al.

    Pharmacologic studies with 7-benzyl-1-ethyl-1,4-dihydro-4-oxo-1,8-naphthyridine-8-carboxylic acid

    J. Pharmacol. Exp. Ther.

    (1967)
  • Y. Agid et al.

    Hyperactivity of remaining dopaminergic neurones after partial destruction of the nigro-striatal dopaminergic system in the rat

    Nature (London) New Biol.

    (1973)
  • H. Akil et al.

    Induction of the intermediate pituitary by stress: synthesis and release of a nonopioid form of β-endorphin

    Science

    (1985)
  • K. Akiyama et al.

    Lasting changes in high affinity 3H-spiperone binding to the rat striatum and mesolimbic area after chronic methamphetamine administration: evaluation of dopaminergic and serotonergic receptor components

    Biol. Psychiatry

    (1982)
  • K. Akiyama et al.

    Increased 3H-spiperone binding sites in mesolimbic area related to methamphetamine-induced behavioral hypersensitivity

    Biol. Psychiatry

    (1982)
  • S. Algeri et al.

    Different adaptive responses by rat striatal dopamine synthetic and receptor mechanisms after repeated treatment with d-amphetamine, methylphenidate and nomifensine

    Pharmacol. Res. Commun.

    (1980)
  • B.M. Angrist et al.

    The phenomenology of experimentally induced amphetamine psychosis: preliminary observations

    Biol. Psychiatry

    (1970)
  • B.M. Angrist et al.

    Psychiatric sequelae of amphetamine use

  • B.M. Angrist et al.

    Central nervous system stimulants: historical aspects and clinical effects

  • H. Anisman

    Vulnerability to depression: contribution of stress

  • H. Anisman et al.

    Catecholamine depletion upon re-exposure to stress: mediation of the escape deficits produced by inescapable shock

    J. Comp. Physiol. Psychol.

    (1979)
  • S.M. Antelman et al.

    Interchangeability of stress and amphetamine in sensitization

    Science

    (1980)
  • S.M. Antelman et al.

    Dopamine autoreceptor subsensitivity: a mechanism common to the treatment of depression and the induction of amphetamine psychosis

    Biol. Psychiatry

    (1981)
  • S.M. Antelman et al.

    Amphetamine as a Stressor

  • S.M. Antelman et al.

    Stress: its effect on interactions among biogenic amines and role in the induction and treatment of disease

  • M. Babbini et al.

    Time-dose relationships for locomotor activity effects of morphine after acute or repeated treatment

    Br. J. Pharmacol.

    (1972)
  • R.C. Baily et al.

    A pharmacological study of changes in central nervous system receptor responsiveness after long-term dexamphetamine and apomorphine administration

    Psychopharmacology

    (1978)
  • S.P. Banerjee et al.

    Amphetamine induces β-adrenergic receptor supersensitivity

    Nature (London)

    (1978)
  • D.S. Bell

    The experimental reproduction of amphetamine psychosis

    Arch. Gen. Psychiatry

    (1973)
  • M. Berglund et al.

    Regional cerebral blood flow in a case of amphetamine intoxication

    Psychopharmacology

    (1980)
  • Cited by (0)

    View full text